Asmall group of people with rectal cancer experienced some miracle as their cancer disappeared after an experimental treatment. According to the New York Times, in a very small clinical trial, 18 patients took a drug called dostarlimab for about six months, and in the end each of them saw their tumor disappear.

just one medicine
Dostarlimab is a drug with a laboratory-produced molecule that acts as a substitute antibody in the human body. All 18 rectal cancer patients were given the same drug and the treatment resulted in complete elimination of cancer in each patient. It was not detected on physical examination, endoscopy, positron emission tomography or PET scan or MRI scan.

Cancer patients will get rid of them
Dr. Luis A. Diaz J, of Memorial Sloan Kettering Cancer Center in New York, said this was the first time in the history of cancer. According to the New York Times, patients included in the clinical trial suffered gruesome conditions during previous treatments to eradicate their cancer, such as chemotherapy, radiation and invasive surgery, resulting in bowel, urinary and even sexual dysfunction. can also be. But nothing like this will happen in this medical trial.

small trial
When 18 cancer patients came for the medical trial, at first they felt that they would have to go through the same tortures as before, but they came to know that no further treatment was required. Only one medicine has to be taken. The conclusion of the drug is now a topic of discussion in the medical world. Speaking to the media outlet Dr Alan P Venuk said that complete remission in every patient is unheard of. Let us inform that Dr. Alan P. Venuk is a colorectal cancer specialist at the University of California.

cancer patients cry with joy
Dr Alan P Venuk described this research as world-first. He also said this was particularly impressive because not all patients suffered significant complications from the trial drug. While there, oncologist Dr. Andrea Cersek, at Memorial Sloan Kettering Cancer Center and co-author of the paper, described the moment patients found out they were cancer-free. He told the New York Times that the patients had tears of joy in their eyes. For the trial, patients took dostarlimab every three weeks for six months. They were all in the same stages of their cancer. It was locally advanced in the rectum but had not spread to other organs. For the time being, cancer researchers reviewing the drug told media outlets that the treatment looks promising, but large-scale trials are needed to see if it will work for more patients.